FDA

Benzodiazepine Information Coalition recently responded to the FDA’s Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products. This document proposed by the FDA seeks to distinguish the difference between addiction,…

On August 31, 2016 the FDA issued a statement about benzodiazepines receiving a black box warning in relation to combining with opiates.  This warning is late and incomplete.  The dangers of opiates and benzodiazepines needed to be addressed,…